Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 07 12 2021
accepted: 31 01 2023
entrez: 17 2 2023
pubmed: 18 2 2023
medline: 22 2 2023
Statut: epublish

Résumé

Cannabis legalization has enabled increased consumption in older adults. Age-related mental, physical, and physiological changes may lead to differences in effects of cannabis in older adults compared to younger individuals. To perform a scoping review to map the evidence regarding the health effects of cannabis use for medical and non-medical purposes in older adults. Electronic databases (MEDLINE, Embase, PsycINFO, Cochrane Library) were searched for systematic reviews (SRs), randomized controlled trials (RCTs) and non-randomized/observational studies (NRSs) assessing the health effects and associations of cannabis use (medical or non-medical) in adults ≥ 50 years of age. Included studies met age-related inclusion criteria or involved a priori identified health conditions common among older adults. Records were screened using a liberal accelerated approach and data charting was performed independently by two reviewers. Descriptive summaries, structured tables, effect direction plots and bubble plots were used to synthesize study findings. From 31,393 citations, 133 publications describing 134 unique studies (26 SRs, 36 RCTs, 72 NRSs) were included. Medical cannabis had inconsistent therapeutic effects in specific patient conditions (e.g., end-stage cancer, dementia), with a number of studies suggesting possible benefits while others found no benefit. For medical cannabis, harmful associations outnumbered beneficial, and RCTs reported more negative effects than NRSs. Cannabis use was associated with greater frequencies of depression, anxiety, cognitive impairment, substance use and problematic substance use, accidents/injuries, and acute healthcare use. Studies often were small, did not consistently assess harms, and did not adjust for confounding. The effects of medical cannabis are inconsistent within specific patient conditions. For older adults, generally, the available evidence suggests cannabis use may be associated with greater frequencies of mental health issues, substance use, and acute healthcare use, and the benefit-to-risk ratio is unclear. Studies with a balanced assessment of benefits and harms may guide appropriate public health messaging to balance the marketing pressures of cannabis to older adults.

Sections du résumé

BACKGROUND
Cannabis legalization has enabled increased consumption in older adults. Age-related mental, physical, and physiological changes may lead to differences in effects of cannabis in older adults compared to younger individuals.
OBJECTIVE
To perform a scoping review to map the evidence regarding the health effects of cannabis use for medical and non-medical purposes in older adults.
METHODS
Electronic databases (MEDLINE, Embase, PsycINFO, Cochrane Library) were searched for systematic reviews (SRs), randomized controlled trials (RCTs) and non-randomized/observational studies (NRSs) assessing the health effects and associations of cannabis use (medical or non-medical) in adults ≥ 50 years of age. Included studies met age-related inclusion criteria or involved a priori identified health conditions common among older adults. Records were screened using a liberal accelerated approach and data charting was performed independently by two reviewers. Descriptive summaries, structured tables, effect direction plots and bubble plots were used to synthesize study findings.
FINDINGS
From 31,393 citations, 133 publications describing 134 unique studies (26 SRs, 36 RCTs, 72 NRSs) were included. Medical cannabis had inconsistent therapeutic effects in specific patient conditions (e.g., end-stage cancer, dementia), with a number of studies suggesting possible benefits while others found no benefit. For medical cannabis, harmful associations outnumbered beneficial, and RCTs reported more negative effects than NRSs. Cannabis use was associated with greater frequencies of depression, anxiety, cognitive impairment, substance use and problematic substance use, accidents/injuries, and acute healthcare use. Studies often were small, did not consistently assess harms, and did not adjust for confounding.
DISCUSSION
The effects of medical cannabis are inconsistent within specific patient conditions. For older adults, generally, the available evidence suggests cannabis use may be associated with greater frequencies of mental health issues, substance use, and acute healthcare use, and the benefit-to-risk ratio is unclear. Studies with a balanced assessment of benefits and harms may guide appropriate public health messaging to balance the marketing pressures of cannabis to older adults.

Identifiants

pubmed: 36800328
doi: 10.1371/journal.pone.0281826
pii: PONE-D-21-38426
pmc: PMC9937508
doi:

Substances chimiques

Medical Marijuana 0

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0281826

Informations de copyright

Copyright: © 2023 Wolfe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

DC is Project Lead for the Canadian Coalition for Seniors’ Mental Health (CCSMH) project on development of Canadian Guidelines on Alcohol, Benzodiazepine, Cannabis and Opioid Use Disorders funded by Health Canada (SUAP) 2017-20; Project Lead for CCSMH Project Cannabis Use and Older Adults: Developing E-Learning Modules and Knowledge Translation Tools for Clinicians and Students, funded by Health Canada (2020-2022). BH has previously received honoraria from Eversana Inc for provision of methodologic advice related to the conduct of systematic reviews. This does not alter the adherence to PLOS Medicine policies on sharing data and materials. All other authors have no conflicts to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Clin Neuropharmacol. 2017 Nov/Dec;40(6):268-272
pubmed: 29059132
Phytomedicine. 2019 May;58:152766
pubmed: 31005719
Harm Reduct J. 2021 Jun 8;18(1):61
pubmed: 34103058
Am J Drug Alcohol Abuse. 2018;44(2):215-223
pubmed: 28481624
Biomed Res Int. 2019 Jun 23;2019:2864384
pubmed: 31341892
Clin J Pain. 2017 Jul;33(7):635-639
pubmed: 27623111
Am J Geriatr Psychiatry. 2015 Dec;23(12):1214-1224
pubmed: 26560511
Front Pharmacol. 2017 Jun 28;8:422
pubmed: 28701957
Ann Oncol. 2011 Sep;22(9):2086-2093
pubmed: 21343383
Diabetes Care. 2010 Jan;33(1):128-30
pubmed: 19808912
Addict Behav. 2004 Aug;29(6):1213-9
pubmed: 15236825
J Am Acad Child Adolesc Psychiatry. 1997 Jan;36(1):45-8
pubmed: 9000780
J Pain Res. 2018 Sep 06;11:1761-1767
pubmed: 30233233
Evid Based Complement Alternat Med. 2014;2014:170396
pubmed: 24817897
Clin Gerontol. 2021 Jan-Feb;44(1):66-79
pubmed: 32842935
Curr Pharm Biotechnol. 2020;21(5):390-402
pubmed: 31793418
BMJ Open. 2020 Feb 28;10(2):e034301
pubmed: 32114474
Pain Pract. 2011 Jul-Aug;11(4):353-68
pubmed: 21087411
Oncologist. 2019 Apr;24(4):549-554
pubmed: 30670598
Am J Geriatr Psychiatry. 2019 Nov;27(11):1161-1173
pubmed: 31182351
Ann Am Thorac Soc. 2018 Oct;15(10):1146-1158
pubmed: 30049223
Eur J Pain. 2018 Mar;22(3):455-470
pubmed: 29034533
Am J Clin Oncol. 1985 Aug;8(4):336-40
pubmed: 3002167
PLoS One. 2017 Apr 25;12(4):e0176416
pubmed: 28441459
Int Psychogeriatr. 2016 Apr;28(4):577-89
pubmed: 26542746
Drug Alcohol Rev. 2021 Feb;40(2):272-280
pubmed: 32964502
Sleep Med Rev. 2019 Aug;46:74-86
pubmed: 31075665
Ann Otol Rhinol Laryngol. 2016 Apr;125(4):317-24
pubmed: 26503964
Lancet Neurol. 2019 Feb;18(2):155-164
pubmed: 30554828
J Clin Psychopharmacol. 2011 Apr;31(2):256-8
pubmed: 21364345
Orthopedics. 2021 Jan 1;44(1):e101-e106
pubmed: 33002174
Int J Clin Pract. 2020 May;74(5):e13477
pubmed: 31922638
J Gen Intern Med. 2018 May;33(5):635-643
pubmed: 29185174
Support Care Cancer. 2002 Jan;10(1):71-5
pubmed: 11777191
Addict Behav. 2020 Sep;108:106437
pubmed: 32330763
Cancer Causes Control. 2002 Sep;13(7):609-16
pubmed: 12296508
Psychopharmacology (Berl). 2015 Jul;232(14):2587-95
pubmed: 25752889
Health Rep. 2020 Feb 19;31(2):11-20
pubmed: 32073644
Isr Med Assoc J. 2017 Feb;19(2):71-75
pubmed: 28457053
Br J Pain. 2017 Aug;11(3):119-133
pubmed: 28785408
Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):301-312
pubmed: 29073741
Neuropsychopharmacology. 2017 Aug;42(9):1752-1765
pubmed: 28327548
Psychopharmacology (Berl). 2006 Nov;188(4):425-44
pubmed: 17019571
Psychopharmacology (Berl). 2006 May;185(4):524-8
pubmed: 16521031
Clin Gerontol. 2021 Jan-Feb;44(1):53-65
pubmed: 32374215
Clin Toxicol (Phila). 2021 Apr;59(4):334-342
pubmed: 32840426
J Pain Symptom Manage. 2018 Feb;55(2):179-188.e1
pubmed: 28923526
Subst Use Misuse. 2019;54(5):852-862
pubmed: 30658548
J Safety Res. 2010 Oct;41(5):445-9
pubmed: 21059462
Neurology. 2001 Dec 11;57(11):2108-11
pubmed: 11739835
Chronic Obstr Pulm Dis. 2018 Jan 24;5(1):46-56
pubmed: 29629404
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
J Clin Oncol. 2006 Jul 20;24(21):3394-400
pubmed: 16849753
Chron Respir Dis. 2011;8(2):109-18
pubmed: 21436223
Neurology. 2015 Jun 9;84(23):2338-46
pubmed: 25972490
Eur J Pain. 2009 May;13(5):472-7
pubmed: 18603457
Am J Drug Alcohol Abuse. 2014 Mar;40(2):118-24
pubmed: 24588418
Clin Cardiol. 2002 Mar;25(3):133-4
pubmed: 11890373
J Am Geriatr Soc. 2019 Oct;67(10):2139-2144
pubmed: 31364159
Int J Geriatr Psychiatry. 1997 Sep;12(9):913-9
pubmed: 9309469
Dtsch Arztebl Int. 2017 Sep 22;114(38):627-634
pubmed: 29017688
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Clin Neuropharmacol. 2014 Mar-Apr;37(2):41-4
pubmed: 24614667
Gen Hosp Psychiatry. 2018 Jan - Feb;50:104-110
pubmed: 29153783
Ann Pharmacother. 2019 Mar;53(3):261-267
pubmed: 30229678
J Gen Intern Med. 2020 Jun;35(6):1813-1820
pubmed: 31965522
Eur J Pain. 2017 Mar;21(3):486-493
pubmed: 27723182
J Am Geriatr Soc. 2009 Jul;57(7):1252-7
pubmed: 19486199
J Psychopharmacol. 2017 Feb;31(2):184-191
pubmed: 27624148
Prev Med Rep. 2020 Aug 11;20:101174
pubmed: 33088675
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Addiction. 2017 Mar;112(3):516-525
pubmed: 27767235
Pain Pract. 2017 Mar;17(3):409-419
pubmed: 27207115
BMJ Support Palliat Care. 2020 Mar;10(1):14-24
pubmed: 31959586
J Glaucoma. 2006 Oct;15(5):349-53
pubmed: 16988594
J Clin Psychiatry. 2019 Jan 29;80(2):
pubmed: 30753761
Evid Based Complement Alternat Med. 2013;2013:510392
pubmed: 23956774
BMC Complement Med Ther. 2020 Jan 15;20(1):12
pubmed: 32020875
Clin Pharmacokinet. 2020 Jun;59(6):747-755
pubmed: 31802404
Acad Med. 2017 Feb;92(2):161-166
pubmed: 27782918
Can J Anaesth. 2006 Aug;53(8):769-75
pubmed: 16873343
Drug Alcohol Depend. 2020 Nov 1;216:108227
pubmed: 32911133
Clin Infect Dis. 2006 Aug 15;43(4):525-31
pubmed: 16838244
Am J Health Behav. 2020 Jul 1;44(4):420-431
pubmed: 32553024
BMJ Support Palliat Care. 2020 Dec;10(4):415-420
pubmed: 31959585
CMAJ. 2018 Sep 4;190(35):E1031-E1032
pubmed: 30181148
World Neurosurg. 2018 Feb;110:e100-e111
pubmed: 29107164
Thorax. 2021 Jan;76(1):29-36
pubmed: 32999059
Accid Anal Prev. 2019 Nov;132:105273
pubmed: 31521874
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):87-105
pubmed: 30706168
J Arthroplasty. 2019 Aug;34(8):1667-1669
pubmed: 31072746
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Schmerz. 2019 Oct;33(5):424-436
pubmed: 31073761
Eur Neuropsychopharmacol. 2014 Sep;24(9):1475-82
pubmed: 25035121
Ann Intern Med. 1979 Dec;91(6):825-30
pubmed: 517882
J Pain. 2015 Jul;16(7):616-27
pubmed: 25843054
Clin Gerontol. 2021 Jan-Feb;44(1):16-24
pubmed: 32186469
Pain. 2021 Jul 1;162(Suppl 1):S45-S66
pubmed: 32804836
Drug Alcohol Depend. 2017 May 1;174:80-90
pubmed: 28319753
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Drug Alcohol Depend. 2016 Aug 01;165:94-102
pubmed: 27282425
Can J Psychiatry. 2020 Jun;65(6):365-376
pubmed: 31835954
J Gen Intern Med. 1999 Apr;14(4):249-54
pubmed: 10203638
Cancer Prev Res (Phila). 2009 Aug;2(8):759-68
pubmed: 19638490
Int Psychogeriatr. 2011 Jun;23(5):732-41
pubmed: 21108863
JAMA. 2015 Jun 23-30;313(24):2456-73
pubmed: 26103030
J Pain Res. 2017 May 02;10:989-998
pubmed: 28496355
JAMA Netw Open. 2019 Nov 1;2(11):e1916318
pubmed: 31774524
Ann Pharmacother. 2009 Jul;43(7):1347-53
pubmed: 19531696
Sleep Med Rev. 2020 Oct;53:101339
pubmed: 32603954
J Addict Dis. 2021 Jan-Mar;39(1):66-73
pubmed: 32935646
Drug Alcohol Depend. 2018 Oct 1;191:374-381
pubmed: 30197051
J Clin Oncol. 2002 Jan 15;20(2):567-73
pubmed: 11786587
J Alzheimers Dis. 2016;51(1):15-9
pubmed: 26757043
Drugs Aging. 2019 Jan;36(1):39-51
pubmed: 30488174
Ann Intern Med. 2017 Sep 05;167(5):319-331
pubmed: 28806817
AIDS. 2002 Mar 8;16(4):543-50
pubmed: 11872997
J Support Oncol. 2008 Mar;6(3):119-24
pubmed: 18402303
Prev Chronic Dis. 2013 Apr 25;10:E65
pubmed: 23618545
Clin Oral Investig. 2020 Jun;24(6):1889-1908
pubmed: 32385655
Am J Gastroenterol. 2021 Jan 1;116(1):106-115
pubmed: 32868629
Eur J Intern Med. 2018 Mar;49:44-50
pubmed: 29398248
Gerontol Geriatr Med. 2019 Apr 26;5:2333721419843707
pubmed: 31065574
Addiction. 2017 Jul;112(7):1193-1201
pubmed: 28301070
Ment Health Clin. 2018 Apr 26;8(3):110-115
pubmed: 29955555
J Emerg Trauma Shock. 2020 Jan-Mar;13(1):35-38
pubmed: 32395047
JAMA Psychiatry. 2014 Mar;71(3):248-54
pubmed: 24382686
Neurology. 2004 Oct 12;63(7):1245-50
pubmed: 15477546
J Psychopharmacol. 2020 Feb;34(2):189-196
pubmed: 31909680
Br J Clin Pharmacol. 2019 Sep;85(9):1888-1900
pubmed: 31222854
Drug Alcohol Depend. 2017 Feb 01;171:97-106
pubmed: 28063338
Front Neurosci. 2018 Aug 14;12:564
pubmed: 30154694
J Pain. 2012 May;13(5):438-49
pubmed: 22483680
Aging Ment Health. 2021 Jun;25(6):1134-1142
pubmed: 32114789
Mov Disord. 2004 Sep;19(9):1102-6
pubmed: 15372606
Can Urol Assoc J. 2020 Jan;14(1):E20-E26
pubmed: 31658007
Drug Alcohol Depend. 2016 Dec 01;169:56-63
pubmed: 27776245
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2152-7
pubmed: 27111561
Br J Clin Pharmacol. 2012 Jul;74(1):42-53
pubmed: 22680341
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):220-234
pubmed: 29400010
Drug Alcohol Depend. 2014 Jun 1;139:33-40
pubmed: 24745475
Am J Drug Alcohol Abuse. 2021 Mar 4;47(2):209-219
pubmed: 33175597
Int J Geriatr Psychiatry. 2018 Feb;33(2):e323-e329
pubmed: 29044798
Diabetes Care. 2016 Oct;39(10):1777-86
pubmed: 27573936
Psychiatry Res Neuroimaging. 2019 Mar 30;285:58-63
pubmed: 30785022
Support Care Cancer. 2018 Sep;26(9):3029-3038
pubmed: 29550881
Ageing Res Rev. 2014 Mar;14:56-64
pubmed: 24509411
Prev Med. 2019 Apr;121:94-98
pubmed: 30763631
PLoS One. 2018 Jul 11;13(7):e0199705
pubmed: 29995914
J Pain Symptom Manage. 2010 Feb;39(2):167-79
pubmed: 19896326
Rheumatology (Oxford). 2006 Jan;45(1):50-2
pubmed: 16282192
J Psychopharmacol. 2014 Nov;28(11):1088-98
pubmed: 25237116
PLoS One. 2019 Sep 9;14(9):e0222361
pubmed: 31498849
JAMA Otolaryngol Head Neck Surg. 2018 Nov 1;144(11):1017-1022
pubmed: 30073295
Am J Geriatr Psychiatry. 2014 Apr;22(4):415-9
pubmed: 23597932
Ann Neurol. 2020 Oct;88(4):712-722
pubmed: 32757413
Drug Alcohol Depend. 2018 Jun 1;187:186-194
pubmed: 29679913
Can Fam Physician. 2018 Feb;64(2):111-120
pubmed: 29449241
Can Fam Physician. 2018 Feb;64(2):e78-e94
pubmed: 29449262
Drugs Aging. 2022 Feb;39(2):153-163
pubmed: 34940961
Mult Scler. 2012 Feb;18(2):219-28
pubmed: 21878454
Subst Abuse Treat Prev Policy. 2020 Feb 17;15(1):12
pubmed: 32066484
J Arthroplasty. 2018 Dec;33(12):3637-3641
pubmed: 30170713

Auteurs

Dianna Wolfe (D)

Ottawa Hospital Research Institute, Ottawa, Canada.

Kim Corace (K)

Institute of Mental Health Research at The Royal, University of Ottawa, Ottawa, Canada.
Department of Family Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Claire Butler (C)

Ottawa Hospital Research Institute, Ottawa, Canada.

Danielle Rice (D)

Ottawa Hospital Research Institute, Ottawa, Canada.

Becky Skidmore (B)

Ottawa Hospital Research Institute, Ottawa, Canada.

Yashila Patel (Y)

Ottawa Hospital Research Institute, Ottawa, Canada.

Premika Thayaparan (P)

Ottawa Hospital Research Institute, Ottawa, Canada.

Alan Michaud (A)

Ottawa Hospital Research Institute, Ottawa, Canada.

Candyce Hamel (C)

Ottawa Hospital Research Institute, Ottawa, Canada.

Andra Smith (A)

School of Psychology, Faculty of Social Sciences, University of Ottawa, Ottawa, Canada.

Gary Garber (G)

Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Amy Porath (A)

Canadian Center for Substance Use and Addiction, Ottawa, Canada.

David Conn (D)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Baycrest Health Sciences, Toronto, Canada.

Melanie Willows (M)

Institute of Mental Health Research at The Royal, University of Ottawa, Ottawa, Canada.
Department of Family Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Hanan Abramovici (H)

Health Canada, Office of Cannabis Science and Surveillance, Ottawa, Canada.

Kednapa Thavorn (K)

Ottawa Hospital Research Institute, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Salmaan Kanji (S)

Ottawa Hospital Research Institute, Ottawa, Canada.
Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Brian Hutton (B)

Ottawa Hospital Research Institute, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH